Trial Profile
Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy Infants 3 to 5 Months of Age: A Randomized, Blinded, Single-center, Positive Controlled Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2015
Price :
$35
*
At a glance
- Drugs DTaP vaccine-Minhai (Primary)
- Indications Pertussis
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Jiangsu Provincial Center for Disease Control and Prevention
- 26 Aug 2015 New trial record